# FDA Inspection 1227324 - Southern Edge Orthpaedics - January 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/southern-edge-orthpaedics/036312fc-4010-430e-849f-bc6e2ac8fb3e
Source feed: FDA_Inspections

> FDA Inspection 1227324 for Southern Edge Orthpaedics on January 16, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227324
- Company Name: Southern Edge Orthpaedics
- Inspection Date: 2024-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1118984 - 2020-01-08](https://www.keypedia.com/records/fda_inspections/southern-edge-orthpaedics/9d630677-d521-44fb-b7cc-7a1c643de7c3)
- [FDA Inspection 1035284 - 2017-11-13](https://www.keypedia.com/records/fda_inspections/southern-edge-orthpaedics/3aef7459-1474-4204-847a-3a904af7a10b)

Company: https://www.keypedia.com/companies/southern-edge-orthpaedics/1434be67-e206-4957-af25-e667347da69c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d